Nebivolol improves coronary flow reserve in patients with idiopathic dilated cardiomyopathy


Creative Commons License

Erdogan D., Güllü H., ÇALIŞKAN M. , Çiftçi Ö., Baycan S., Yıldırır A., ...Daha Fazla

HEART, cilt.93, ss.319-324, 2007 (SCI İndekslerine Giren Dergi) identifier identifier

  • Cilt numarası: 93 Konu: 3
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1136/hrt.2006.091751
  • Dergi Adı: HEART
  • Sayfa Sayıları: ss.319-324

Özet

Background: Impaired coronary flow reserve (CFR) is a significant predictor of poor prognosis in patients with idiopathic dilated cardiomyopathy (IDC). Nebivolol reduces mortality and morbidity in patients with heart failure and left ventricular dysfunction, including cases caused by IDC.